News

Each Rare Cancer Accounts for less than 40,000 new cases each year.

Targeting Prevention to Reduce the High Human Toll of Rare Cancers

POSTED: October 1, 2024
SOURCE: Cancer Prevention Science Blog

At the Rare Cancers Prevention and Interception workshop this year, cancer researchers from across the United States, Canada, and the United Kingdom and from across disciplines sought to address many of the issues that can…
Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used
During chemotherapy for an advanced blood cancer, Stacey Blansky vaped marijuana daily for her nausea and used cannabis oil for anxiety and stress. The decision to add these complex, plant-derived substances to ease her… Learn more
POSTED: 2/24/2021
SOURCE: Cancer Prevention Science Blog
Up close view of Aspirin tablets.
Second Report Suggests No Benefit to Starting Aspirin Therapy for Cancer Prevention for Adults 70 and Older
Millions of older Americans take aspirin daily to reduce their risk for heart disease and colorectal cancer. But, new data suggests this protective edge for colorectal cancer comes only if they begin taking aspirin before… Learn more
POSTED: 2/11/2021
SOURCE: Cancer Prevention Science Blog
AUTHOR: Susan Jenks
A meeting of 4 medical professional around a table.
NCORP PARTNRS Workshop Executive Summary is Available
The executive summary is available of an inaugural workshop to encourage and forge partnerships between oncologists, primary care providers and medical specialists to promote accrual to clinical cancer control and prevention… Learn more
POSTED: 2/4/2021
SOURCE: NCI NCORP News
Screen grab of the virtual meeting with the First Lady, Dr. Jill Biden.
NCORP Network Is Highlighted at NCI World Cancer Day Event with Dr. Biden

Dr. Jill Biden, Ed.D., First Lady of the United States, joined NCI leaders and staff for a special virtual event marking World Cancer Day, February 4. Among the progress highlighted was the work of the NCI Community… Learn more
POSTED: 2/4/2021
SOURCE: DCP News
A bottle of Naproxen placed atop a table with some tablets displayed.
Study With Common Pain Drug Shows Change in Immune Biomarkers, Highlights Pathway for Prevention of Colorectal Cancer in People with Lynch Syndrome
An over-the-counter drug, readily available to consumers for years, may open a new option for preventing colorectal cancer in high-risk individuals.
It's not the mouse that roared but the quiet mouse behind the… Learn more
POSTED: 2/3/2021
SOURCE: Cancer Prevention Science Blog
AUTHOR: Susan Jenks
Histological slide (H & E stain at x300) showing prostate cancer.
Early Detection Research Network Marks 20 Years
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the network in 2000 with the goal of identifying and harnessing biomarkers as a way of… Learn more
POSTED: 12/21/2020
SOURCE: AACR Cancer Research Cataylst Blog
Scientific Achievements During 2020: An Unforgettable Year of Progress in the NCI Division of Cancer Prevention
As this unforgettable year of 2020 comes to an end, I am reaching the milestone of my first 6 months as Director of the NCI Division of Cancer Prevention (DCP). It has been a whirlwind of virtual meetings and introductions.… Learn more
POSTED: 12/17/2020
SOURCE: Cancer Prevention Science Blog
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
Portraits of Principal investigators Katherine D. Crew, M.D., M.S., (left) and Rita Kukafka, Dr.P.H., M.A. (right)
Making Informed Choices on Incorporating Chemoprevention Into Breast Care: Q & A with Dr. Katherine Crew on the MiCHOICE Trial
The SWOG Cancer Research Network is opening to accrual the MiCHOICE Trial to study the use of decision support tools by women with high-risk breast conditions and their healthcare providers to choose among chemoprevention… Learn more
POSTED: 12/8/2020
SOURCE: Cancer Prevention Science Blog